DermaGold™, the first electro-hydraulic therapy system to specifically utilize the biologic effects of acoustic pressure pulses, offers a revolutionary method for increasing local blood circulation and relieving muscle aches and pain.
DermaGold’s patented SoftWave™ technology combines heat, electromagnetic, acoustic, and light energies to stimulate certain therapeutic biologic effects, specifically:
- Improved vascularity
- Promotion of NO (nitric oxide)
- Promotion of growth factors (VEGF, BMP´s, OP´s, etc.)
- Migration (and differentiation) of stem cells
Innovative Applicator
Intensive research by MTS engineers produced an innovative SoftWave™ applicator designed specifically to provide mechanical stimulation to the skin in the form of acoustic pressure pulses. Based on proven MTS technology, the DermaGold™ applicator delivers the specific energy volume and energy distribution specially required to stimulate therapeutic biologic effects.
Treatment without Anesthesia
Because of the DermaGold™ applicator’s propagation of unfocused acoustic pressure pulses, the surface of the skin is not directly exposed to the point of highest energy flux density. Therefore the pain usually associated with pressure pulse treatment is significantly reduced. Thus DermaGold™ treatment for skin lesions does not require anesthesia. The number of treatments required depends on the indication and on the treatment area.
Patented Technology
DermaGold™ uses patented SmartTrode intelligent electrode technology. The SmartTrode adjusts itself automatically for the selected level of output power to ensure consistent and effective pressure pulses and thus, optimal treatment quality.
Device not approved for marketing, distribution or use in the United States.